Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2012

01-06-2012 | Original Article

Osteopontin Ablation Attenuates Progression of Colitis in TNBS Model

Authors: Helieh S. Oz, Jian Zhong, Willem J. S. de Villiers

Published in: Digestive Diseases and Sciences | Issue 6/2012

Login to get access

Abstract

Introduction

OPN has been implicated in the inflammatory response to Crohn’s disease. We hypothesized that OPN deficiency protects against different stages of TNBS-induced colitis in a modified model that mimics Crohn’s disease.

Material and Methods

OPN-deficient and wildtype mice were treated intracolonically with TNBS and euthanized during acute, sub-acute and chronic colitis.

Results

TNBS-treated wildtype mice developed severe colitis, but OPN-deficient mice were significantly protected. Wildtype mice showed significant infiltration of inflammatory cells including macrophages, and colonic transmural thickening that progressed to strictures, increased matrix collagen deposits (X2 fold), and granuloma formation. These pathological findings were partially attenuated by OPN deficiency. The inflammatory marker, serum amyloid A (SAA), markedly increased in sub-acute stages regardless of OPN status. Conversely, OPN deficiency significantly reduced concentration of SAA in the acute and chronic stages. Secretory OPN was upregulated particularly in acute stage in wildtypes (P < 0.001) and as expected not present in OPN-deficient animals. Flow cytometry analysis of splenic macrophages revealed significant increases in scavenger receptors, macrosialin and F4/80 markers’ expression in wildtypes.

Conclusions

Our data support the role of OPN in induction of inflammation and establishment of chronic colitis. Therefore, OPN may represent a target for therapeutic intervention in Crohn’s disease.
Literature
1.
go back to reference Caillier S, Barcellos LF, Baranzini SE, et al. Multiple sclerosis genetics group. Osteopontin polymorphisms and disease course in multiple sclerosis. Genes Immun. 2003;4:312–315.PubMedCrossRef Caillier S, Barcellos LF, Baranzini SE, et al. Multiple sclerosis genetics group. Osteopontin polymorphisms and disease course in multiple sclerosis. Genes Immun. 2003;4:312–315.PubMedCrossRef
2.
go back to reference Sato T, Nakai T, Tamura N, et al. Osteopontin/Eta-1 upregulated in Crohn’s disease regulates the Th1 immune response. Gut. 2005;54:1254–1262.PubMedCrossRef Sato T, Nakai T, Tamura N, et al. Osteopontin/Eta-1 upregulated in Crohn’s disease regulates the Th1 immune response. Gut. 2005;54:1254–1262.PubMedCrossRef
3.
go back to reference Mishima R, Takeshima F, Sawai T, et al. High plasma osteopontin levels in patients with inflammatory bowel disease. J Clin Gastroenterol. 2007;41:123–125.CrossRef Mishima R, Takeshima F, Sawai T, et al. High plasma osteopontin levels in patients with inflammatory bowel disease. J Clin Gastroenterol. 2007;41:123–125.CrossRef
4.
go back to reference Oz HS, Ebersole JL. Application of prodrugs to inflammatory diseases of the gut. Molecules. 2008;13:452–474 (review). Oz HS, Ebersole JL. Application of prodrugs to inflammatory diseases of the gut. Molecules. 2008;13:452–474 (review).
5.
6.
go back to reference Hume DA, Allan W, Hogan PG, Doe WF. Immunohistochemical characterization of macrophages in human liver and gastrointestinal tract: expression of CD4, HLA-DR, OKM1, and the mature macrophage marker 25F9 in normal and diseased tissue. J Leuko Biol. 1987;42:474–484.PubMed Hume DA, Allan W, Hogan PG, Doe WF. Immunohistochemical characterization of macrophages in human liver and gastrointestinal tract: expression of CD4, HLA-DR, OKM1, and the mature macrophage marker 25F9 in normal and diseased tissue. J Leuko Biol. 1987;42:474–484.PubMed
7.
go back to reference Oshitani N, Campbell A, Kitano A, Kobayashi K, Jewell DP. In situ comparison of phenotypical and functional activity of infiltrating cells in ulcerative colitis mucosa. J Pathol. 1996;178:95–99.PubMedCrossRef Oshitani N, Campbell A, Kitano A, Kobayashi K, Jewell DP. In situ comparison of phenotypical and functional activity of infiltrating cells in ulcerative colitis mucosa. J Pathol. 1996;178:95–99.PubMedCrossRef
8.
go back to reference Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut. 1994;35:669–674.PubMedCrossRef Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut. 1994;35:669–674.PubMedCrossRef
9.
go back to reference Grimm MC, Pullman WE, Bennett GM, Sullivan PJ, Pavli P, Doe WF. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J Gastro Hepatol. 1995;10:387–395.CrossRef Grimm MC, Pullman WE, Bennett GM, Sullivan PJ, Pavli P, Doe WF. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J Gastro Hepatol. 1995;10:387–395.CrossRef
10.
go back to reference Patarca R, Wei FY, Singh P, Morasso MI, Cantor H. Dysregulated expression of the T cell cytokine Eta-1 in CD4–8-lymphocytes during the development of murine autoimmune disease. J Exp Med. 1990;172:1177–1183.PubMedCrossRef Patarca R, Wei FY, Singh P, Morasso MI, Cantor H. Dysregulated expression of the T cell cytokine Eta-1 in CD4–8-lymphocytes during the development of murine autoimmune disease. J Exp Med. 1990;172:1177–1183.PubMedCrossRef
11.
go back to reference Lampe MA, Patarca R, Iregui MV, Cantor H. Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J Immunol. 1991;147:2902–2906.PubMed Lampe MA, Patarca R, Iregui MV, Cantor H. Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J Immunol. 1991;147:2902–2906.PubMed
12.
go back to reference Yamamoto N, Sakai F, Kon S, et al. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clinic Invest. 2003;112:181–188. Yamamoto N, Sakai F, Kon S, et al. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clinic Invest. 2003;112:181–188.
13.
go back to reference Masuda H, Takahashi Y, Asai S, Hemmi A, Takayama T. Osteopontin expression in ulcerative colitis is distinctly different from that in Crohn’s disease and diverticulitis. J Gastro. 2005;40:409–413.CrossRef Masuda H, Takahashi Y, Asai S, Hemmi A, Takayama T. Osteopontin expression in ulcerative colitis is distinctly different from that in Crohn’s disease and diverticulitis. J Gastro. 2005;40:409–413.CrossRef
14.
go back to reference Oz HS, Chen T, Nagasawa H. Comparative efficacies of two cysteine prodrugs and a glutathione delivery agent in a colitis model. Transl Res. 2007;150:122–129.PubMedCrossRef Oz HS, Chen T, Nagasawa H. Comparative efficacies of two cysteine prodrugs and a glutathione delivery agent in a colitis model. Transl Res. 2007;150:122–129.PubMedCrossRef
15.
go back to reference Zhong J, Eckhardt ER, Oz HS, Bruemmer D, de Villiers W. Osteopontin deficiency protects mice from DSS-induced colitis. Inflam Bowel Dis. 2006;12:790–796.CrossRef Zhong J, Eckhardt ER, Oz HS, Bruemmer D, de Villiers W. Osteopontin deficiency protects mice from DSS-induced colitis. Inflam Bowel Dis. 2006;12:790–796.CrossRef
16.
go back to reference Oz HS, Chen T, Ebersole JL. A model for chronic mucosal inflammation in IBD and periodontitis. Dig Dis Sci. 2010;55:2194–2202.PubMedCrossRef Oz HS, Chen T, Ebersole JL. A model for chronic mucosal inflammation in IBD and periodontitis. Dig Dis Sci. 2010;55:2194–2202.PubMedCrossRef
17.
go back to reference Reinholt FP, Hultenby K, Oldberg A, Heinegard D. Osteopontin—a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA. 1990;87:4473–4475.PubMedCrossRef Reinholt FP, Hultenby K, Oldberg A, Heinegard D. Osteopontin—a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA. 1990;87:4473–4475.PubMedCrossRef
18.
go back to reference Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol. 2000;19:615–622.PubMedCrossRef Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol. 2000;19:615–622.PubMedCrossRef
19.
go back to reference Ashkar S, Weber GF, Panoutsakopoulou V, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 2000;287:860–864.PubMedCrossRef Ashkar S, Weber GF, Panoutsakopoulou V, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 2000;287:860–864.PubMedCrossRef
20.
go back to reference Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol. 1998;152:353–358.PubMed Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol. 1998;152:353–358.PubMed
21.
go back to reference Heilmann K, Hoffmann U, Witte E, et al. Osteopontin as two-sided mediator of intestinal inflammation. J Cell Mol Med. 2009;13:1162–1174.PubMedCrossRef Heilmann K, Hoffmann U, Witte E, et al. Osteopontin as two-sided mediator of intestinal inflammation. J Cell Mol Med. 2009;13:1162–1174.PubMedCrossRef
22.
go back to reference Da Silva AP, Pollett A, Rittling SR, Denhardt DT, Sodek J, Zohar R. Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death. J Cell Physiol. 2006;208:629–639.PubMedCrossRef Da Silva AP, Pollett A, Rittling SR, Denhardt DT, Sodek J, Zohar R. Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death. J Cell Physiol. 2006;208:629–639.PubMedCrossRef
23.
go back to reference Grassl GA, Valdez Y, Bergstrom KS, Vallance BA, Finlay BB. Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology. 2008;134:768–780.PubMedCrossRef Grassl GA, Valdez Y, Bergstrom KS, Vallance BA, Finlay BB. Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology. 2008;134:768–780.PubMedCrossRef
24.
go back to reference Ardite E, Sans M, Panes J, Romero F, Pique JM, Fernandez-Checa J. Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab Invest. 2000;80:735–744. Ardite E, Sans M, Panes J, Romero F, Pique JM, Fernandez-Checa J. Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab Invest. 2000;80:735–744.
25.
go back to reference Oz HS, Ebersole JL. A novel murine model for chronic inflammatory alveolar bone loss. J Periodontal Resh. 2010;45:94–99.CrossRef Oz HS, Ebersole JL. A novel murine model for chronic inflammatory alveolar bone loss. J Periodontal Resh. 2010;45:94–99.CrossRef
26.
go back to reference Grisham MB, Volkmer C, Tso P, Yamada T. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology. 1991;101:540–547.PubMed Grisham MB, Volkmer C, Tso P, Yamada T. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology. 1991;101:540–547.PubMed
27.
go back to reference Rath HC, Schultz M, Freitag R, et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun. 2001;69:2277–2285.PubMedCrossRef Rath HC, Schultz M, Freitag R, et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun. 2001;69:2277–2285.PubMedCrossRef
28.
go back to reference Hazelgrove KB, Flynn RS, Qiao lY, Grider JR, Kuemmerle JF. Endogenous IGF-I and αvβ3 integrin ligands regulate increased smooth muscle growth in TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1230–G1237. Hazelgrove KB, Flynn RS, Qiao lY, Grider JR, Kuemmerle JF. Endogenous IGF-I and αvβ3 integrin ligands regulate increased smooth muscle growth in TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1230–G1237.
Metadata
Title
Osteopontin Ablation Attenuates Progression of Colitis in TNBS Model
Authors
Helieh S. Oz
Jian Zhong
Willem J. S. de Villiers
Publication date
01-06-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-2009-z

Other articles of this Issue 6/2012

Digestive Diseases and Sciences 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.